Eagle Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $55.5M | Sell |
|
|||||
|
2024
Q1 | $62.1M | Buy |
|
|||||
|
2023
Q4 | $42.1M | Sell |
|
|||||
|
2023
Q3 | $38.8M | Sell |
|
|||||
|
2023
Q2 | $38M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $44M | Buy |
|
|||||
|
2020
Q4 | $46.8M | Sell |
|
|||||
|
2020
Q3 | $43.8M | Sell |
|
|||||
|
2020
Q2 | $70.7M | Buy |
|
|||||
|
2020
Q1 | $35.9M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $32.3M | Buy |
|
|||||
|
2017
Q4 | $33.2M | Buy |
|
|||||
|
2017
Q3 | $30M | Buy |
|
|||||
|
2017
Q2 | $27.8M | Buy |
|
|||||
|
2017
Q1 | $22.1M | Sell |
|
|||||
|
2016
Q4 | $21.1M | Buy |
|
|||||
|
2016
Q3 | $16M | Sell |
|
|||||
|
2016
Q2 | $13.7M | Buy |
|
|||||
|
2016
Q1 | $14.2M | Sell |
|
|||||
|
2015
Q4 | $18.2M | Buy |
|
|||||
|
2015
Q3 | $16M | Buy |
|
|||||
|
2015
Q2 | $18.8M | Buy |
|
|||||
|
2015
Q1 | $15.8M | Buy |
|
|||||
|
2014
Q4 | $11.1M | Sell |
|
|||||
|
2014
Q3 | $8.96M | Buy |
|
|||||
|
2014
Q2 | $7.6M | Sell |
|
|||||
|
2014
Q1 | $8.55M | Sell |
|
|||||
|
2013
Q4 | $8.86M | Sell |
|
|||||
|
2013
Q3 | $14.7M | Buy |
|
|||||
|
2013
Q2 | $10.8M | Buy |
|